GW Pharmaceuticals Net Income

GWPH -- USA Stock  

USD 102.65  0.19  0.19%

GW Pharmaceuticals net-income fundamental analysis lookup allows you to check this and other indicators for GW Pharmaceuticals Plc or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

GW Pharmaceuticals Net Income Analysis

Net income is the profit of a company for the reporting period which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most watched numbers by money managers as well as individual investors.
 2009 2016 2018 2019 (projected)
Revenues USD 12,737,000  12,730,000  14,639,500  14,284,930 
Revenues 12,737,000  12,730,000  14,639,500  131,580,000 
Net Income 
(Rev + Gain) 
(Exp + Loss) 
More About Net Income | All Equity Analysis
GW Pharmaceuticals Net Income  =
(104.47 M)
GW Pharmaceuticals ValuationFundamentalsBuy or Sell

GW Pharmaceuticals Net Income Over Time Pattern

 GW Pharmaceuticals Net Income 

About Net Income

Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin which measures income as a percentage of sales.
Compare to competition

GW Pharmaceuticals Net Income Assessment

Accumulated Other Comprehensive Income
Based on recorded statements GW Pharmaceuticals Plc reported net loss of -1.0447E8. This is 130.61% lower than that of the Healthcare sector, and significantly lower than that of Drug Manufacturers?General industry, The Net Income for all stocks is 118.3% higher than the company.

Did you try this?

Run Equity Search Now


Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

GW Pharmaceuticals current financial ratios